Clinical Study
Early Pseudoprogression following Chemoradiotherapy in Glioblastoma Patients: The Value of RANO Evaluation
Figure 3
Kaplan-Meier analysis of overall survival curves according to different progression groups: true-progressive disease (tPD), blue; Pseudoprogression (psPD), green; Nonprogressive disease (nPD), yellow; and different response assessment criteria: (a), Macdonald; (b), RANO.
